Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Intra-Cellular raises $60M

Neurology company Intra-Cellular Therapies Inc. (New York, N.Y.) raised about

Read the full 107 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE